Transformed mycosis fungoides: bridging to allogeneic stem cell transplantation with brentuximab vedotin

Although mycosis fungoides (MF) is characterized by an indolent course of disease (disease-specific 5-year survival rate of up to 88%), disease progression or death occurs in nearly 30% of MF patie...